Navigation Links
Intrepid Investment Bankers LLC Advises Newport Medical Instruments, Inc. in its Sale to Covidien plc
Date:5/1/2012

LOS ANGELES, May 1, 2012 /PRNewswire/ -- Intrepid Investment Bankers LLC ("Intrepid"), a leading middle market investment banking firm, today announced the sale of Newport Medical Instruments, Inc. ("Newport") to Covidien plc (NYSE: COV).  The transaction closed on May 1, 2012.  Intrepid acted as the exclusive M&A advisor to Newport in connection with the transaction. 

(Logo:  http://photos.prnewswire.com/prnh/20120315/LA70428LOGO)

Newport is a physician-led company, focused solely on the design and manufacture of dependable, life improving ventilators that are affordable for caregivers worldwide. Newport's products are sold in the United States and more than 115 countries worldwide.

Covidien is a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices.  Covidien creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. With 2011 revenue of $11.6 billion, Covidien has 41,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries.

"This transaction highlights both companies' commitment to driving innovation and growth in the respiratory care sector by expanding their ventilator portfolio and global presence," said Dr. Hong-Lin Du, President of Newport.  "Newport shareholders were very pleased with the strategic guidance and process advice Intrepid has provided."

Mr. Ed Bagdasarian, Managing Director of Intrepid, commented, "We were pleased to have the opportunity to work with the Newport owners and management team to lead the company through the sale process.  After three decades of building the company, its owners decided to entertain strategic discussions with partners that would help accelerate the fulfillment of several exciting growth opportunities.  We were honored to play a part in selecting its future partner and completing a transaction that will help Newport realize its growth opportunities."

The Intrepid team included Ed Bagdasarian, Steve Davis, Adam Abramowitz, Jeremy Lai and Meghan Stenger.

About Intrepid Investment Bankers LLC 

Intrepid Investment Bankers LLC, based in Los Angeles, California, is a mergers and acquisitions and corporate finance advisory firm focused on the middle-market. Intrepid was founded in 2010 by the former principals of Barrington Associates, a firm that grew to become a leading national middle market M&A advisor before its acquisition by Wells Fargo in 2006. Intrepid's services include M&A advisory, equity and debt capital raising and providing strategic advice in complex securities transactions. The firm focuses on the middle market corporate finance needs of entrepreneur and family-owned businesses, private equity sponsors and major corporations. Collectively, the senior team at Intrepid brings over 100 years of mergers and acquisitions advisory experience and has advised on over 250 transactions spanning a broad range of industries, including consumer products and services, industrial manufacturing, healthcare products and services, building products, business services and retail. www.intrepidib.com Member FINRA/SIPC. 


'/>"/>
SOURCE Intrepid Investment Bankers LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta
2. IRIDEX to Present at Upcoming Investment Conferences
3. HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical
4. Survey of Biomedical Industry CEOs Finds Lack of Investment and Regulatory Environment Threaten Future Growth and Innovation
5. Quanterix Announces Strategic Investment From IQT
6. Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years
7. Healthcare Services No Longer "Restricted" in Chinas Foreign Investment Catalogue
8. AuraSense Therapeutics Secures Series B Equity Investment
9. Cardium and SourceOne Global Partners Enter Into Cross-Strategic Equity Investment with Plans to Jointly Develop Nutritional Supplements and Medical Foods
10. Physicians Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX
11. Physicians Capital Investments Announces Pedro Vergne-Marini, MD Named to Beckers ASC Review "350 People in the ASC Industry to Know"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016  EIP Pharma, LLC ( www.eippharma.com ) ... neflamapimod (previously code named VX-745), with the results ... that demonstrated significant Alzheimer,s disease relevant pharmacological activity.  ... Study 303 (6-week treatment) are the subject of ... (CTAD) scientific conference in San Diego, ...
(Date:12/8/2016)... Research and Markets has announced the addition of the ... ... global chromatography market to grow at a CAGR of 5.42% during the ... based on an in-depth market analysis with inputs from industry experts. The ... years. The report also includes a discussion of the key vendors operating ...
(Date:12/8/2016)... 8, 2016  Economic growth in the United States ... supply management executives in their December 2016 Semiannual Economic ... recovery that began in mid-2009, as indicated in the ... ® . The manufacturing sector is optimistic about growth ... manufacturing industries, and the non-manufacturing sector indicates that 14 ...
Breaking Medicine Technology:
(Date:12/8/2016)... Fla (PRWEB) , ... December 08, 2016 , ... ... smarter modes of access for customers and employees that are both engaging and ... 7 with Service Smart Technology, the software company revealed today its plans to ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... up in 2006 as a non-profit organization to unite pharmaceutical and healthcare companies ...
(Date:12/8/2016)... ... 2016 , ... STAT courier is pleased to announce that due to customer ... are expanding their presence in Dallas. One of the most exciting parts for STAT ... to the Dallas and Forth Worth market. STAT takes pride in treating their employees ...
(Date:12/8/2016)... City, Ga (PRWEB) , ... December 08, 2016 ... ... moving as soon after surgery as possible. With this in mind, SIGVARIS has ... thrombosis (DVT or blood clot) during bed rest and provide the benefits of ...
(Date:12/8/2016)... , ... December 08, 2016 , ... Vida ... an $18M Series B led by Canvas Ventures . Other investors include Nokia ... scale its mobile platform to serve more consumers who are managing chronic conditions ...
Breaking Medicine News(10 mins):